Mammakarzinom: adjuvante Therapie mit Trastuzumab: Herceptin Adjuvant (HERA) Trial Study, B-31- und N9831-Studie

Author: Mallmann P.  

Publisher: Springer Publishing Company

ISSN: 0020-9554

Source: Der Internist, Vol.47, Iss.11, 2006-11, pp. : 1183-1185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next